Majestic Research secures ROC approval for AGM extension to Oct 2026

1 min read | Published on 16 Sept 2026, 07:45 PM |Updated on 16 Sept 2026, 07:45 PM

Reviewed by

Naman SScanX News Team

Add as a preferred
source on Google

Key Highlights

ROC Bangalore approved one-month AGM extension for Majestic Research
New deadline for FY26 AGM is October 31, 2026
Company had originally requested extension until December 31, 2026
Regulator advised future compliance with Companies Act timelines

*this image is generated using AI for illustrative purposes only.

Majestic Research Services and Solutions Limited has obtained approval from the Registrar of Companies, Karnataka, to extend the timeline for convening its Annual General Meeting for FY26.

The ROC granted a one-month extension, allowing the company to hold the meeting on or before October 31, 2026. This follows a board resolution dated September 2, 2026, in which the company applied for a three-month extension until December 31, 2026.

Regulatory Approval Details

The Registrar of Companies issued the order on September 15, 2026, citing Section 96(1) of the Companies Act, 2013. The original statutory deadline for holding the AGM was September 30, 2026.

While the company requested an extension until the end of December, the regulator approved only one additional month. The order advises the company to ensure careful compliance with the Companies Act provisions in the future.

Detail	Information
Company	Majestic Research Services and Solutions Limited
Original AGM Deadline	September 30, 2026
Requested Extension	Until December 31, 2026
Approved Extension	Until October 31, 2026
Regulatory Body	ROC Bangalore

The company will intimate the specific date of the AGM in due course. The disclosure was made under Regulation 30 of the SEBI Listing Obligations and Disclosure Requirements Regulations, 2015.

What specific operational or administrative challenges caused Majestic Research Services to miss the original AGM deadline?

How might the ROC's partial approval and warning about future compliance impact the company's regulatory standing with SEBI?

Will the delay in convening the AGM affect the timeline for declaring dividends or finalizing FY26 financial results?

Majestic Research seeks AGM extension to Dec 2026 for IBC plan

0 min read | Published on 02 Sept 2026, 03:31 PM |Updated on 02 Sept 2026, 03:31 PM

Reviewed by

Anirudha BScanX News Team

Add as a preferred
source on Google

Key Highlights

Majestic Research Services & Solutions Ltd seeks AGM extension to Dec 31, 2026
Board approved application to ROC Karnataka under Companies Act Section 96(1)
Delay attributed to IBC Resolution Plan implementation and account reconstitution
Shareholder record reconciliation and financial statement audit also cited as reasons

*this image is generated using AI for illustrative purposes only.

Majestic Research Services and Solutions Limited has sought a three-month extension for its annual general meeting, pushing the deadline to December 31, 2026.

The company’s Board of Directors approved the proposal during a meeting held on September 2, 2026. The application will be submitted to the Registrar of Companies (ROC), Karnataka, under Section 96(1) of the Companies Act, 2013.

Regulatory Context

The request cites special reasons necessitating the delay in holding the AGM for the financial year ended March 31, 2026. These reasons include:

Implementation of the Resolution Plan under Section 31 of the Insolvency and Bankruptcy Code (IBC), 2016, as approved by the National Company Law Tribunal (NCLT).
Reconstitution of accounts.
Pending capital reduction and restructuring corporate actions.
Updation and reconciliation of shareholder records following the capital reduction.
Proposed listing of shares.
Finalization and audit of financial statements for the relevant period.

The board meeting commenced at 2:00 pm and concluded at 2:22 pm.

How might the successful implementation of the IBC Resolution Plan impact Majestic Research's operational stability and future growth trajectory?

What are the potential timelines and regulatory hurdles for the proposed listing of shares following the capital reduction?

Could the reconstitution of accounts and pending restructuring actions affect the company's credit rating or ability to secure new financing?